FOXO1 and pancreatic ductal adenocarcinoma: Furthermore, cancer stem cells (CSCs) in pancreatic ductal carcinoma are FOXO1-negative, and the loss of FOXO1 might be a more accurate CSC marker than the expression of CD133 or ALDH1 [17].